Search for more clinical trials
New Methods of Distribution of a Self Sampler Kit for Cervical Cancer Screening
Conditions
Cervical Cancer Cin Grade
Conditions: official terms
Uterine Cervical Neoplasms
Conditions: Keywords
cervical cancer, prevention, screening
Study Type
Observational
Study Phase
N/A
Study Design
Observational Model: Cohort, Time Perspective: Prospective
Overall Status
Not yet recruiting
Summary
The opportunity of a home, self-collected sample, opens the chance to remove some of the barriers that may discourage women from participating to screening programmes or performing HPV (Human Papilloma Virus)-test. Self-sampling is less time consuming and invasive as compared with tests performed at a clinic. It allows for privacy, reduces discomfort and women know nobody would have to handle their body.
Study hypothesis: The use of a self-sampler may increase the recovery of non-responders women at cervical cancer screening.
Study hypothesis: The use of a self-sampler may increase the recovery of non-responders women at cervical cancer screening.
Detailed Description
In a previous trial (ISRCTN96071600) the investigators tested on 2400 women, compliance with self sampler device (PantaRhei Devices, Zeist, the Netherlands).
With this study the investigators analyze the response to two channels of transmission of the device (a model of device easier, and less expensive than the previous), such as screening for colon cancer.
The shipment of the device at home and taking on a local pharmacy. Involving 15000 women non-responders to previous calls in five different screening programs in Italy (Rome, Bologna, Abruzzo region, Molise region, Veneto region).
With this study the investigators analyze the response to two channels of transmission of the device (a model of device easier, and less expensive than the previous), such as screening for colon cancer.
The shipment of the device at home and taking on a local pharmacy. Involving 15000 women non-responders to previous calls in five different screening programs in Italy (Rome, Bologna, Abruzzo region, Molise region, Veneto region).
Criteria for eligibility
Healthy Volunteers: No
Maximum Age: 64 Years
Minimum Age: 35 Years
Gender: Female
Criteria: Inclusion Criteria:
All women (aged 35-64 years) non-responding to the screening invitation in the previous year and eligible for recall
Exclusion Criteria:
does not meet inclusion criteria
All women (aged 35-64 years) non-responding to the screening invitation in the previous year and eligible for recall
Exclusion Criteria:
does not meet inclusion criteria
Location
AUSL4 Teramo
Teramo, TE, Italy
Status: Not yet recruiting
Contact: Emma Altobelli, Prof. - 0861420280 - amedeo.lattanzi@aslteramo.it
Start Date
September 2012
Completion Date
March 2013
Sponsors
Azienda Sanitaria Locale 4, Teramo
Source
Azienda Sanitaria Locale 4, Teramo
Record processing date
ClinicalTrials.gov processed this data on July 28, 2015
ClinicalTrials.gov page